Table 1 Detailed inclusion and exclusion criteria
From: Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
Inclusion criteria | Exclusion criteria |
|---|---|
- Original publications in English language with full-text available | - Not related to defined outcomes of interest (Ocular adverse events) |
- Assessed occurrence of ocular adverse events | - Not related to immune checkpoint inhibitors |
- Included cancer patients treated with (a combination of) immune checkpoint inhibitors | - In vitro/not in humans |
- Comprehensive description of the case report | - Language other than English |